Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Defining interferon β response status in multiple sclerosis patients

Rudick, Richard A., Lee, Jar‐Chi, Simon, Jack, Ransohoff, Richard M., Fisher, Elizabeth·2004·Annals of Neurology

Abstract

IFN‐β is effective in reducing relapses and magnetic resonance imaging (MRI) lesions in multiple sclerosis (MS). It is assumed that individual therapeutic responses vary, but methods to identify IFN‐β responsiveness have not been validated. Our objective was to evaluate methods to classify IFN‐β responder status using relapses and MRI lesions. Data was analyzed from 172 patients who were followed up in a placebo‐controlled clinical trial of IFN‐β1a for 2 years. Patients were classified as responders or nonresponders using (1) the number of relapses during the 2‐year trial; (2) the number of new T2 lesions after 2 years; and (3) the number of gadolinium‐enhancing lesions at year 1 and year 2 on study. Outcomes included 2‐year change in the Expanded Disability Status Scale, Multiple Sclerosis Functional Composite, and brain parenchymal fraction. We found that subgroups with high on‐study relapse numbers had more disease progression, differences between responder subgroups were similar in the IFN‐β1a and placebo arms. In contrast, subgroups with high numbers of new MRI lesions had significantly more disease progression only in the IFN‐β1a arm. Baseline characteristics failed to account for differential outcome. New MRI lesion activity during IFN‐β1a treatment correlates with poor response to IFN‐β1a. MRI classification may facilitate rational therapeutic decisions, better clinical trial designs, and studies correlating biomarkers with therapeutic response. Ann Neurol 2004

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.20224

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 217

Metadata

Authors
Rudick, R. A., Lee, J., Simon, J., Ransohoff, R. M., & Fisher, E.
Venue
Annals of Neurology
Publisher
Wiley
Published
2004-09-09
Volume
56
Issue
4
Pages
548-555
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2155510219
Cited by
217
References
2
FWCI
7.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defining interferon β response status in multiple sclerosis patients. https://app.cochat.ai/papers/10.1002/ana.20224
The paper
Rudick, R. A., Lee, J., Simon, J., Ransohoff, R. M., & Fisher, E. (2004). Defining interferon β response status in multiple sclerosis patients. Annals of Neurology. https://doi.org/10.1002/ana.20224

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.